DOC Updates podcast

What's Next—Hypercortisolism in Uncontrolled Diabetes and Resistant Hypertension: When and How to Test for Excess Cortisol

11/17/2026
0:00
31:33
Rewind 15 seconds
Fast Forward 15 seconds

Once thought to be rare, an emerging understanding shows that hypercortisolism plays a significant role in both diabetes and hypertension. In this special episode of DOC Updates, Neil Skolnik explores the downstream consequences of undiagnosed hypercortisolism and how to make an effective diagnosis.

This special episode is sponsored with support from Corcept.

Presented by:

Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

Pamela Kushner, MD, Clinical Professor of Family Medicine at the University of California at Irvine and Medical Director of the Kushner Wellness Center in Los Angeles.

Vivian Fonseca, MD, Professor of Medicine and Pharmacology Assistant Dean for Clinical Research Tullis Tulane Alumni Chair in Diabetes Chief, Section of Endocrinology Tulane University Health Sciences

Selected References:

Buse, et al. Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes. Diabetes Care 20 November 2025; 48 (12): 2012–2020. https://doi.org/10.2337/dc24-2841

DeFronzo et al. Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment. Diabetes Care 20 November 2025; 48 (12): 2036–2044. https://doi.org/10.2337/dc25-1055

MOMENTUM: Hypercortisolism Present in 1-in-4 with Resistant Hypertension. HCP Live, March 2026

More episodes from "DOC Updates"